throbber
Environmental Health Perspectives
`Vol. 21, pp. 255-267, 1977
`
`Toxicology of the Fluoroalkenes:
`Review and Research Needs
`
`by J. Wesley Clayton*
`
`In this review of the published literature on the toxicology of fluoroalkenes several features emerge and
`research needs are evident. The fluoroalkenes vary widely in acute inhalation toxicity. Those, such as
`perfluoroisobutylene, PFIB, the most highly toxic member, attacks the pulmonary epithelium of rats
`eventuating in edema and death after a delay of about one day. Other fluoroalkenes, such as hexafluoro-
`propylene (HFP) or chlorotrifluoroethylene (CTFE), also cause pulmonary injury but at lower concentra-
`tions produce concentration dependent changes in the renal concentrating mechanism of the rat. Changes
`in the CNS of rats and rabbits have also been reported for CTFE. CTFE, in repeated exposures, has
`produced blood pressure changes in dogs, CNS effects and changes in the erythropoietic system. This
`variety of responses indicates the need for investigation. Chronic effects have not been sufficiently studied
`for PFIB and HFP. Thus pointing up the desirability for study. Mechanisms of action research for
`fluoroalkenes is an important area of need. While several ideas have been suggested, there are no data to
`support them. The nucleophilic sensitivity of the fluoroalkenes and the potential carcinogenic effects
`stemming therefrom suggests a need field for investigation. We also can readily perceive the needs for the
`evaluation of effects on reproduction (including mutagenesis and teratogenesis), metabolism pulmonary
`functions, cellular function and structure. Epidemiologic studies on occupationally exposed populations
`are desirable in order to adequately define human health hazard from these fluorocarbons.
`
`Introduction
`
`Because of legitimate concern about the tox-
`icologic and environmental effects of widely used
`fluoroalkane propellants such as dichlorodi-
`fluoromethane (fluorocarbon I2),
`trichloro-
`fluoromethane (fluorocarbon 11) and others which
`have been in commercial use for decades, other
`fluorocarbons such as the fluoroalkenes, have only
`been cursorily evaluated for toxic and other
`hazards. It is the purpose of this paper to review the
`relevant published literature on the toxicology of
`several fluoroalkenes and to define areas of need for
`future toxicologic research.
`That fluoroalkenes are important in toxicologic
`evaluation, has been pointed out by Krespan (1).
`He points out that it was recognized more than 40
`years ago that fluoroalkenes such as tetra-
`fluoroethylene and chlorotrifluoroethylene could be
`polymerized by free-radical catalysis. This de-
`velopment led naturally to a preparation of several
`kinds of fluoropolymers formed from the variety of
`fluoroalkenes which were subsequently synthe-
`
`*Toxicology Program, University of Arizona, Tucson,
`Arizona 85721.
`
`insofar as health
`sized. Thus, fluoroalkenes,
`hazards were concerned, were treated mainly as in-
`dustrial chemicals, prepared by the manufacturer,
`subjected to appropriate toxicity evaluation, and
`handled with the caution considered their due.
`
`Consequently, they rarely if ever came in contact
`with the public as the fluoroalkanes have. How-
`ever,
`isolated accidental exposures in industry
`brought the toxic potential of the fluoroalkenes
`dramatically to our attention. It would seem that
`the industrial controls requisite to the safe manufac-
`ture and handling of these chemicals precluded sig-
`nificant health hazards. Accordingly,
`little tox-
`icologic research beyond single and shortterm re-
`peated inhalation exposures has been available in
`the published literature.
`
`Chemistry
`
`Fluoroalkenes differ from their hydrocarbon
`counterparts in that the area of the double bond
`tends not to be rich, but deficient in electrons be-
`cause of the strong electronegativity of the fluorine
`atoms attached to adjacent carbons. Thus fluoroal-
`kenes are subject
`to nucleophilic attack and are
`prey for bases or other nucleophiles, e.g., fluoride,
`
`December 1977
`
`Page 1 of 13
`
`255
`
`Arkema Exhibit 1141
`
`Page 1 of 13
`
`Arkema Exhibit 1141
`
`

`
`OH or NH2. Krespan (I) shows how the fluoride
`ion (F_) is related to the chemistry of the fluoroal-
`kenes in the same way as the proton (H+) is related
`to the alkene hydrocarbons:
`
`H" + c+H,=cHcH,cH, = CH,,C*HCH,CH3
`
`: CH3CH = CHCH3 + H+
`
`(1)
`
`F‘ + cF,=CFcF,cF, = cF,c-FcF,cF,
`
`= CF,CF=CFCF3+ F-
`
`(2)
`
`In reaction (2), migration of the double bond is ac-
`complished by the movement of the nucleophile F‘
`into the double-bond electrophilic center with sub-
`sequent leaving of F‘ to proceed down the chain.
`The same event for the alkene hydrocarbons is
`shown in Eq. (1). In alkene hydrocarbons, the area
`of the double bond is electron rich thus attracting an
`electrophilic proton.
`Where a locus of the type present in the double
`bond area of the fluoroalkenes exerts a major influ-
`ence on its electronic properties,
`it would seem
`likely that biological activity would be largely influ-
`enced by the area of low electron density between
`adjacent carbons and the consequent susceptibility
`to nucleophilic attack. According to Chambers and
`Mobbs (2) and Cook and Pierce (3), susceptibility
`of fluoroalkenes to nucleophilic attack is in the fol-
`lowing order:
`
`(CF3)2—C——-CF, > CF2=CFCF3 > CF2=CF2
`
`The inhalation toxicity is in the same order per-
`fluoroisobutylene > hexafluoropropylene > tetra-
`fluoroethylene (Table 1). However, experimental
`data bearing on this potential relationship are lack-
`ing, as is information on the biologic or toxicologic
`mechanisms of action among the fluoroalkenes. For
`example, Danishevskii and Kochanov (4) claim that
`the high toxicity of perfluoroisobutylene (PFIB)
`stems from in vivo carbonyl fluoride formation.
`Against this view, however, COF2 is lower in acute
`inhalation toxicity than PFIB (5), and it produces
`different biologic sequelae. The picture of COF2
`toxicity is that of hydrogen fluoride. The approxi-
`mate lethal concentration (ALC) of COF2 (4-hr ex-
`posures in rats) is 100 ppm, which would corre-
`spond to 200 ppm of HF, a concentration in the
`lethal range. It is only conjecture, but the suscepti-
`bility of PFIB to nucleophilic attack might consti-
`tute the basis for its high toxicity.
`
`256
`
`Page 2 of 13
`
`Acute Inhalation Toxicity
`
`Summaries of acute inhalation toxicity of several
`fluoroalkenes are found in Tables 1 and 2. A wide
`
`range of toxicity is readily apparent in Table l. and
`while it may seem that toxicity in this class is in-
`versely related to the number of fluorine atoms, in-
`adequate knowledge of toxic mechanisms at present
`obviates any such conclusion. It is more likely that
`some biological action related to the double bond,
`as postulated above, is predominantly responsible
`for the high toxicity of PFIB, rather than its com-
`plement of eight fluorine atoms. The toxic
`mechanism however remains to be demonstrated.
`
`Table 1. Inhalation toxicity of several fluoroalkenes.“
`
`Structure
`CH,=CHF
`CF2=CH,
`
`No. F
`atoms
`1
`2
`
`Acute toxicity for rats”
`ALC,
`LC5.,
`ppm
`ppm
`>800,000"
`—
`128,000
`—
`>800,000°
`—
`—
`40,000
`—
`3,000
`0.5, 0.76“
`—
`
`4
`6
`8
`
`CF,=CF,
`CF,CF=CF,
`((;}=3),c=cF2
`"Data of Clayton (5).
`"4-hr exposures except where noted.
`‘80% CH2=CHF, 20% O2; 12.5-hr exposure.
`480% CH2=CF,, 20% 0,; 19-hr exposure.
`90.5 ppm exposure was 6 hr; the 0.76 ppm exposure was 4 hr.
`
`Table 2. Inhalation toxicity of several halogenated alkenes.“
`
`Structure
`CCl,=CH2
`CHCl=CCl,
`CCl,=CCl,
`CCl,=CF,
`CClF=CF,
`
`No. F No. Cl
`atoms
`atoms
`0
`2
`0
`3
`0
`4
`2
`2
`3
`I
`
`Acute toxicity for rats”
`ALC,
`LC,-,0
`ppm
`ppm
`32,000
`—
`8,000
`—
`4,000
`—
`1,000
`—
`—-
`1000
`
`“Data of Clayton (5).
`“All 4-hr exposures.
`
`Generally, fluorinated alkenes are less toxic than
`chlorinated alkenes. Table 3 brings together three
`homologous pairs illustrating this point. A direct
`relationship between toxicity and number of
`chlorine atoms is illustrated by the sequence sig-
`nifying acute inhalation toxicity of these chlorinated
`alkenes as judged by animal inhalation exposures.
`In order of decreasing toxicity we have:
`
`CCl,=CCl, > CI-ICl=CCI, > CI-I,=CCI, > CH,=CI-ICl
`
`Illustrative of fluoroalkenes of relatively low tox-
`icity are vinyl fluoride (VF) (CH2=CHF) and vin-
`ylidene fluoride (VF2) (CH2=CF2). As indicated
`
`Environmental Health Perspectives
`
`Page 2 of 13
`
`

`
`Table 3. Toxicity comparisons among some
`halogenated alkenes (rats).“
`
`Structure
`CH,=CHCl
`CHg=*CI-IF
`CH2=CCl,
`
`CH2=CF,
`CCl2=CCl,
`CF,=CF,
`
`Acute inhalation toxicity, ALC,
`ppm (by volume)”
`>250,000‘
`>800,000"
`32,000
`128,000
`>800,000‘
`4,000
`40,000
`
`“Data of Clayton (5).
`"All 4-hr exposures except where noted.
`‘Guinea pigs, 8-hr exposure.
`"80% CH2=CHF, 20% 0,; 12.5 hr exposure.
`980% CH,=CF,, 20% 0,; 19-hr exposure.
`
`by Table 3, high concentrations were not lethal for
`rats exposed to either VF or VF2 for 12.5 and 19 hr,
`respectively. In the work by Lester and Greenberg
`(6) there was no organ damage reported. Limperos
`(7) conducted repeated exposures with male and
`female rats inhaling 100,000 ppm VF 7 hr/day, 5
`days/week, for 30 exposures. There were no
`fatalities; rats gained weight normally, showed no
`obvious behavioral changes, or tissue damage, as
`evaluated by microscopic examination.
`Fluoroalkenes of moderate to slight toxicity may
`be exemplified by tetrafluoroethylene (TFE), hexa-
`fluoropropylene (HFP), and chlorotrifluoro-
`ethylene (CTFE). These compounds are irritating to
`the respiratory tract and lungs in lethal concen-
`trations as judged by animal exposures, but in addi-
`tion they also can cause kidney injury (8-10). Single
`exposures of rats to varying concentrations of CTFE
`have produced evidence of kidney dysfunction.
`Radford (11), as reported by Zapp (8) demonstrated
`that laboratory rats ingesting a dry diet ad libitum
`voluntarily limited their water intake and conse-
`quently excreted a maximally concentrated urine.
`Tracking the water intake, urine volume, and solute
`concentration of several rats, Radford found a high
`degree of uniformity in the response of individual
`rats for these variables. This suggested an exquisite
`response system relating to the concentrating
`mechanism of the renal tubular cells in the rat. When
`this mechanism was disturbed, water intake and
`urine volume increased while solute concentration
`decreased. In order to determine possible “dose”
`relationships, Radford exposed groups of male rats
`for 4 hr in an inhalation chamber to 125, 240, 340, or
`460 ppm of chlorotrifluoroethylene (CTFE). Work
`reported by Hood et al. (10) had disclosed kidney
`injury in rats inhaling CTFE. In Radford’s work,
`half of the rats inhaling 460 ppm died within one
`week after exposure. The remaining animals sur-
`vived and were observed for signs of renal dysfi1nc-
`
`December 1977
`
`Page 3 of 13
`
`tion for 39 days. Figure 1 depicts the effects of the
`various levels of CTFE on the rat’s ability to con-
`centrate its urine. Of the three variables shown,
`body weight was the least sensitive to CTFE. Rats
`inhaling 460 ppm showed weight depression as com-
`pared to the pre-exposure values. At 340, 240, and
`125 ppm,
`it is debatable whether or not the body
`weight curves show a weight depresssion related to
`CTFE exposure because food consumption was also
`down slightly. Variables reflecting renal function
`were the most sensitive indices of effects. All treat-
`ment levels exerted an effect on the renal concentrat-
`ing mechanism, and this effect varied in a dose-
`related fashion.
`
`M
`’°°
`4
`
`|
`I
`
`am;vow:ml/layFOODIIIYAIEooovWEIGHT9-0-/ur.3S.=asis9a8
`
`
`
`
`nolll
`IIIICOI¢IYRA‘Il0I
`
`
`250 no mun: Yemin -I on
`.;.g.4.;.g.:oIzscsc1I9noI
`
`DAYS AFTER EXPOSURE
`
`($365110;
`
`FIGURE 1. Effects of single exposure of chlorotrifluoroethylene:
`(
`) 125 ppm; (A) 240 ppm; (o) 340 ppm; (9) 460 ppm. Mean
`values for groups of six male rats.
`
`Figure 2 illustrates the dose dose/concentration re-
`lationships derived from the foregoing CTFE expo-,
`’ sures and several doses administered by subcutane-
`ous injections of mercuric chloride, a comparative
`control. Functional impairment of the kidney can
`therefore be expressed as a decline of urine solute
`concentration and increased water intake with in-
`
`257
`
`Page 3 of 13
`
`

`
`ZIOO
`
`PrI~
`Exposurc
`Range
`
`mOs/liver
`
`
`
`MINIMUMURINESOLUTECONCENTRATION
`
`500
`
`15(1)
`nooo
`NOMINAL concsmnmons (ppm, val)
`
`2000
`
`FIGURE 3. Effects of hexafluoropropylene on rat renal concen-
`tration for 4 hr exposure.
`
`of the renal tubules. Clayton conducted kidney func-
`tion studies on these rats and showed that sublethal
`concentrations caused increased urine volume which
`reached a high point 2 to 4 days after exposure and
`gradually returned to lower volumes in the 14-day
`observation period following exposure. These find-
`ings agree with those observed by Radford. We need
`now to study this post-exposure phase in more de-
`tail. It would be important to follow the anatomical
`changes (light and electron microscopy) occurring at
`several points along the curves plotted in Figure 2
`describing renal function changes. Of particular sig-
`nificance is the so-called recovery phase. Is it in fact
`“recovery?” What is the significance of these events
`for humans accidentally exposed to these fluoroal-
`kenes?
`
`Kochanov (12) exposed groups of rats and rabbits
`for 2 hr each to various concentrations of CTFE.
`The LC5o for both rats and rabbits was determined as
`5,040 ppm. The concentrations resulting in death of
`,all animals from the 2-hr exposure were 5544 ppm
`and 7560 ppm for rabbits and rats, respectively. The
`animals became first excited, apathetic, then dys-
`pneic and inactive during exposure. There was also
`impairment of coordination at the highest concen-
`tration of approximately 10,000 ppm. Deaths oc-
`curred during the first few days after exposure. His-
`tology of animals that died disclosed congestion of
`intemal organs, changes in the brain, and necrosis of
`
`Environmental Health Perspectives
`
`me met, me.
`FIGURE 2. Efiects of (X) I-IgCl, and (o) CTFE on rat kidneys.
`
`creasing CTFE concentrations. The threshold con-
`centration for this effect appears to be around 100
`ppm, approximately one tenth the 4-hr, rat LC5o of
`1000 ppm (5). Hexafluoropropylene (HFP) and tet-
`rafluoroethylene (TFE) provoked similar responses
`in the rat kidney, but these were both less active in
`this regard than CTFE. For HFP the 4-hr rat LC50
`was found to be 3000 ppm, and the threshold con-
`centration for impairment of the rat renal concentrat-
`ing function was approximately 400 ppm (Fig. 3)
`about one tenth the LC5o, as with CTFE. For TFE
`these values were 40,000 ppm and 500 ppm respec-
`tively (5). These findings in rats suggests a physiolog-
`ical basis for setting workplace standards for the
`fluoroalkenes, but it is clear that detailed studies, say
`on isolated renal tubules and electron microscopy,
`are needed to elucidate the finer aspects of the
`phenomenon just described. Furthermore, other
`fluoroalkenes, e.g., VF, VF2, dichlorohexa-
`fluorobutene, hexafluorocyclobutene, and per-
`fluoroisobutene need to be subjected to evaluation
`of effects on renal function. In addition, long-term,
`repeated, low level exposures are needed.
`Microscopic examination of tissues from male rats
`exposed to 800, 900, 1000, or 1200 ppm of CTFE for
`4 hr was reported by Hood et al. (10). The LC5., was
`calculated as 1000 ppm. Death occurred 1-11 days
`after the inhalation exposure. Pathology revealed
`pulmonary edema, pleural effusion and degeneration
`
`258
`
`Page 4 of 13
`
`Page 4 of 13
`
`

`
`the kidney tubules. The authors did not report on the
`histology of animals that survived exposure. Neither
`did they describe any changes in the water intake or
`volume of urine excreted. It is also notable that the
`
`LCT50 of 10,000 ppm-hours reported by Kochanov
`(I2) is about 2.5 times that of 4000 ppm-hours deter-
`mined by Hood et al. (10). This raises the question of
`sample identity. Neither of the two groups reported
`on the composition of their samples or the contami-
`« nants .
`
`Paulet and Desbrousses (I3) exposed Swiss mice
`and Wistar rats to hexafluoropropylene for time
`periods of 0.5-8 hr. The results of the experiments of
`these authors are summarized in Table 4. The lowest
`lethal concentrations for the 8-hr exposures were 400
`ppm for mice and 2000 ppm for rats. Deaths
`occurred during the succeeding 10 days follow-
`ing exposures. At the high levels deaths occurred
`within one day.
`
`Table 4. Acute inhalation toxicity of hexalluoropropylene.“
`
`Duration of
`exposure, hr
`lé
`2
`4
`6
`8
`
`Mice
`3000
`1200
`750
`680
`600
`
`LC’“’’ ppm
`
`Rats
`15,750
`4,000
`2,800
`2,350
`2,400
`
`“Data of Paulet and Desbrousses (I3).
`
`Danishevskii and Kochanov (4) report studies on
`rats exposed to hexafluoropropylene,
`tetra-
`fluoroethylene and chlorotrifluoroethylene. The fol-
`lowing lethal levels were reported for 2-hr expo-
`sures: hexafluoropropylene, 3,240—13,365 ppm; tet-
`rafluoroethylene,
`25,000
`ppm;
`chlorotri-
`fluoroethylene, 7,560 ppm. Histology of rats which
`died after exposure to these three fluoroalkenes
`showed pulmonary congestion and edema with de-
`generative changes in liver and kidney. These levels
`would be expected to be lethal on the grounds of
`previously described studies. Changes that might
`have occurred in urine volume and water intake
`
`were not reported.
`Investigating the toxicity of tetrafluoroethylene,
`Zhemerdei (I4) exposed rats and rabbits for 2 hr
`each to concentrations in the range of 5000 to
`100,000 ppm by volume. The lowest lethal concen-
`tration for the rats exposed was 25,000 ppm. The
`time of death of the rats was in direct proportion to
`the concentration and varied from 3 hr after expo-
`sure to 16 days and more. Rats exposed to 50()0 ppm
`showed no signs of toxicity. At higher concentra-
`tions, there was inactivity, rapid respiration and
`somnolence. After exposure ended, there was de-
`pression, slow respiration, inactivity and occasional
`
`December 1977
`
`Page 5 of 13
`
`tetanic convulsions elicited by external stimuli. For
`rabbits, the lowest lethal concentration was 40,000
`ppm. At 10,000 ppm there were no signs of toxicity;
`above 10,000 ppm, there was inactivity and a de-
`crease in respiration rate. After exposure, the rab-
`bits appeared apathetic, lost appetite, and the rate
`of respiration increased. Rabbits which succumbed
`experienced a convulsion before death. Pathology
`of rats and rabbits disclosed congestion of organs,
`especially the brain, hemorrhage of the lungs and
`spleen, and degenerative changes in the kidneys.
`Considering probable differences in the kind and
`quantity of contaminants in the various samples,
`the work reported by Danishevskii and Kochanov
`(4) and Zhermerdei (14) reveals the same order of
`toxicity for the several fluoroalkenes as reported
`earlier.
`
`Referring to Table I, perfluoroisobutylene
`(PFIB) is by far the most toxic fluoroalkene known.
`Clayton (15) reported the acute inhalation of PFIB.
`Table 5 summarizes the data from the exposures,
`and Figure 4 discloses time/concentration relation-
`ships with mortality. Rats succumbing to PFIB
`showed progressively severe tachypnea and
`cyanosis and died as a result of pulmonary edema
`with no effects discernible in other organ systems.
`From these data and similar animal experiments
`with phosgene, PFIB (LCT5o = 3 ppm-hr) is about
`ten times as toxic as phosgene (LCT50 = 25 to 40
`ppm-hr). The acute toxic action of these two irri-
`tants appears to be directed solely at the lung.
`Longer-term exposures to PFIB at levels without
`deleterious effects on the lung could exert other
`actions—possibly on the kidney, as has been re-
`ported for CTFE and HFP.
`Exposures of rats and mice to PFIB are reported
`by Danishevskii and Kochanov (4). In 2-hr expo-
`sures all rats succumbed to a concentration of 1.8
`
`ppm (vol) (3.7 ppm-hr), and the maximum tolerated
`concentration was 1.6 ppm. Mice tolerated a con-
`centration of 0.6 ppm while 1.2 ppm (2.4 ppm-hr)
`and 1.8 ppm (3.7 ppm-hr) were the minimum lethal
`and absolute lethal concentrations, respectively.
`Histology disclosed pulmonary hemorrhages and
`edema and degenerative changes in the kidney,
`viz., albuminous, granular dystrophy and plas-
`molysis [sic] of the cells of tubules. Degenerative
`changes, sometimes fatty, in the liver were also re-
`ported. A relationship between the degree of the
`histologic reaction and the level of exposure is not
`delineated by these authors. This work is in agree-
`ment with that already summarized with respect to
`lung changes. Changes in other organs however are
`not consistent.
`
`With the exception of Kochanov’s work on
`CTFE (12), Russian investigations of the toxicity of
`
`259
`
`Page 5 of 13
`
`

`
`Table 5. Summary of single exposures of rats to perfluoroisobutylene.“
`
`Mortality ratio,
`Time of
`Nominal concn,
`exposure,
`(no. dead/no.
`Clinical signs
`Pathological
`
`ppm (by vol.)
`hr
`exposed)
`changes
`1.0
`4.25
`2/2
`Acute pulmonary
`5.33
`edema
`6.00
`Acute pulmonary
`edema
`
`0.5
`
`2/2
`
`Dyspnea, cyanosis, gasp-
`ing convulsions
`Slight dyspnea after ex-
`posure. Both died over-
`night
`None during exposure.
`Slight increase in respi-
`ration rate and weight
`loss next day. Recov-
`ered thereafter
`
`
`0.3
`
`6.00
`
`0/2
`
`None observed
`9 days after
`exposure
`
`“Data of Haskell Laboratory, unpublished.
`
`RANGE
`
` LETHAL
`
`NON- LETHAL
`RANGE
`
`CONCENTRATIONOFPFIB,ppm(volI
`
`+EXPOSURE TIME - mmuies
`
`:l__J I;
`no
`200300
`
`FIGURE 4. Rat mortality from inhaled perfluoroisobutene.
`
`CTFE, TFE, HFP, and PFIB disclose the same
`order of toxicity that American authors report.
`However, the histologic changes appeared to differ
`somewhat; these need to be clarified.
`In their studies on fluoride ion excretion by rats
`inhaling fluoroalkenes, Dilley et al. (16) found that
`hexafluoropropene (30 min exposure at 2600 ppm)
`produced increased urine excretion as well as in-
`creased fluoride excretion. The eiuretic effect was
`most pronounced and lasted longer with H FP com-
`pared to the other fluorocarbons investigated. Rats A
`inhaling HFP displayed histologic changes in the
`kidneys which were described as dilation and ne-
`crosis of the proximal
`tubules, cytoplasmic
`eosinophila, and sloughing into the intraluminal
`areas. The authors conclude that the fluoroalkenes
`
`260
`
`Page 6 of 13
`
`or a metabolite thereof caused the increase in urine
`volumes observed. Because only one concentration
`was used,
`it
`is not possible to determine the
`threshold levels of these fluorocarbons. However,
`the work is in agreement with those previously cited
`which demonstrated renal toxicity for the fluoroal-
`kenes studied.
`
`Dilley et al. (16) also studied the effects of tetra-
`fluoroethylene (TFE), trifluoroethylene, vinylidene
`fluoride, vinyl fluoride, and hexafluoroethane.
`Changes like those reported for HFP were ob-
`served, however, the extent of these were not as
`marked as those noted for HFP. It is likely that the
`changes would be dose-related and that experi-
`ments at additional levels would reveal this.
`
`Repeated Inhalation Toxicity
`
`Few studies of the effects of repeated animal ex-
`posures to fluoroalkenes have been reported, yet
`these fluorocarbons possess the greatest potential
`for biological effects.
`
`Chlorotrifluoroethylene (CTFE),
`Repeated Exposures
`
`After Hood et al. (10) had determined the LC5o
`for CTFE in rats, viz., 1000 ppm, these inves-
`tigators went on to study the effects of repeated
`exposures, Phases I and II.
`In Phase 1, three dogs, male and female rats,
`male guinea pigs, and male rabbits were exposed to
`300 ppm CTFE, 4 hr per day, 5 days per week.
`Eighteen exposures were actually conducted. Rats
`showed a slight weight loss but no other signs of
`toxic action. There were changes in the renal
`tubules. In the guinea pigs there was one death after
`the sixth exposure, loss of body weight, and normal
`histology. Rabbits showed two deaths after the fourth
`and fifth exposures, loss of body weight, normal
`
`Environmental Health Perspectives
`
`Page 6 of 13
`
`

`
`histology. In dogs, blood pressure and heart rate
`were normal;
`there was mild leucopenia and
`granulocytopenia during the second and third day of
`each week. Mild encephalopathy was seen in two
`dogs. A third dog was not sacrificed but exposed as
`follows: 300 ppm,
`three times; 400 ppm, seven
`times; 500 ppm, two times; 600 ppm, one time; 800
`ppm, three times; and 1000 ppm, one time. At each
`of these steps there was temporary leucopenia.
`After recovery of the white cell count, the concen-
`tration of CTFE was raised to the next level. An
`increase in the red blood cell count was detected
`
`during the 400 ppm exposure; plasma cholesterol
`rose slightly.
`Following the exposure to 1000 ppm, the dog was
`subjected by Clayton, as reported by Hood (10) to
`the additional stress of exercise using a treadmill,
`the objective being an attempt to simulate a real-life
`problem where accidental exposure could be as-
`sociated with considerable muscular exertion by the
`individual. Heart rate was the parameter chosen to
`assess this potential problem. Upon exercise, the
`dog became weak and was unable to complete a
`standard exercise pattern that his cohorts had no
`difficulty in completing. Heart rate was signifi-
`cantly elevated to 200 beats/min. No changes in
`cardiac rhythm were detected even though a high,
`endogenous epinephrine level was probably
`reached. After his exercise period, recovery to base
`line heart rate was slowed.
`
`In order to segregate the effects of the parade of
`exposures which had preceded the final one at 1000
`ppm, a fourth dog was exposed once, for 4 hr, to
`1000 ppm. Effects on this animal were not nearly as
`dramatic. No acute toxic effects were reported, and
`there was a transient drop in the white cell count
`from 7100 to 2200 in the day following the exposure.
`Pathologic examination revealed degenerative
`neural changes which were not pronounced in the
`dog which had received multiple exposures than in
`the dog which had been exposed once to 1000 ppm.
`Short-tenn, repeated exposures in dogs therefore
`cause transient leucopenia, an adaptive component
`('2), persistent erythrocytosis, a slight rise in plasma
`cholesterol, and encephalopathy without clinically
`detectable neurological abnormalities.
`These findings strongly indicated that long-term,
`repeated exposures could ultimately damage the
`adaptive competence of the dog and provoke clini-
`cally observable neurological changes to accom-
`pany the encephalopathy. Accordingly, in Phase II,
`a long-term investigation was carried out by these
`workers. Rats, rabbits, guinea pigs, and dogs were
`exposed to CTFE concentrations beginning at 15
`ppm (38 exposures) and raised progressively to 30
`ppm (28 exposures), 50 ppm (93 exposures), 100
`
`December 1977
`
`Page 7 of 13
`
`ppm (56 exposures), and 150 ppm (104 exposures).
`The exposures lasted 6 hr each day (excepting holi-
`days) and were conducted 5 days per week for 14
`months. Guinea pigs and rabbits were not affected,
`clinically or anatomically by the exposure regimen.
`Rats developed degenerative changes in the renal
`tubules which were discovered at the end of the 14
`
`months of exposure. It is not known from the report
`of this work when or at what concentration of those
`
`named above the kidney response occurred. From
`Radford’s data previously cited, one would expect
`the change to occur at the beginning of the 100-150
`ppm exposure series and progressively worsen for
`the remainder of the 14 months.
`
`In the group of dogs in this experiment, overt
`signs of toxicity were not noticeable through the
`exposures up to 150 ppm. At this level, neurological
`disturbances were observed in two dogs after 27 or
`64 exposures. Changes in blood pressure became
`statistically significant shortly after the 100 ppm
`series was begun (Fig. 5). There was some hint of
`these changes near the finish of the 50 ppm series. It
`is probable that extending the 50 ppm level beyond
`the 93 exposures would have gradually increased
`the departure of the blood pressure parameters
`from control limits.
`
`Hematological evidence of changes attributable
`to CTFE was also picked up during the 50 ppm
`series and became statistically significant at the
`higher levels. These responses were consistent with
`changes in hematologic measurements made during
`Phase II, viz., leucopenia, erythrocytosis (RBC,
`Hemoglobin, Hematocrit), granulocytopenia, and a
`slight elevation in plasma cholesterol in two dogs.
`Pathologic examination of the dogs revealed
`muscle atrophy and degenerative changes in the
`brain, spinal cord, spinal and peripheral nerves. On
`the grounds of these data, the authors suggest that
`20 ppm would be a safe “ceiling” concentration for
`workers potentially exposed 8 hr/day. Human data
`were evidently not available for entry into this
`judgement. Accidental human exposure has not
`been reported. Therefore the mode of toxic action
`ofCTFE in humans is, at present, not known. Until
`this point is delineated, those who might be exposed
`to CTFE or supervise those who might, could, from
`the animal data just discussed, anticipate almost
`any organ system to be affected—respiratory,
`nervous, renal or hematopoietic.
`The Russian investigator, Kochanov has pub-
`lished results of chronic animal toxicity experi-
`ments on CTFE (12). In this study, seven rabbits
`were exposed 4 hr daily except Sundays and holi-
`days for 58 days to 500 ppm of CTFE. Three rab-
`bits died during this sequence at days 16, 29, and 30.
`The concentration of CTFE was lowered on ex-
`
`261
`
`Page 7 of 13
`
`

`
`
`
` inIIICH
`
`APIIL
`I955
`
`IA!
`
`l
`
`Jllll '
`
`svsrouc Paessunzi
`
`DI ASTOLIC PRESSURE
`
`PULSE PRESSURE
`
`flwir _
`
`_
`
`.\
`V,
`i
`
`iu
`
`PULSE RATE
`
`AVERAGE was
`
`M V
`
`was! wt
`
`(H
`l
`tn nomm otcmnl mum mun
`'
`
`l03t
`
`-
`
`-
`
`_
`
`'
`
`}
`
`I50‘
`
`V00‘
`
`_...__
`
`.’‘_.
`
`
`
`-.—-.—'—fi/o--—+.2>-
`
`Will
`
`OCTO
`
`UTIII
`
`LS
`
`V!
`
`I
`
`iii
`
`UGlS'
`
`'rmum moi
`
`mm
`
`llullll
`
`Ill
`
`lmullli
`
`lUIf
`
`JUlV
`I954
`
`iiA
`
`
`
`FIGURE 5. Vital signs in dog on long-term exposure to chlorotrifluoroethylenc.
`
`posure number 59_ to 250 ppm with 6-hr exposures
`conducted. Rabbits experienced a reduction in
`motor activity and respiratory rate. Although var-
`ied. the CTFE group showed a decrease in rate of
`body weight gained as compared to the control
`group. Alkaline phosphatase values dropped stead-
`ily throughout the 81 to I30 day exposure period.
`Cholinesterase activity was increased 2 to I0 times
`by CTFE exposures. No significant differences in
`organ to body weight ratios were noted. His-
`topathologic examination revealed a widespread
`congestion of liver. spleen. and kidneys.
`On comparing Kochanov‘s results (12) with those
`of Hood et al. (10), a noteworthy similarity
`emerges. Hood and co-workers exposed three rab-
`bits at a lower concentration (300 ppm, Phase I and
`50-150 ppm, Phase 11). Neither of these proved in-
`jurious to the rabbits, although it is not given in
`their report whether or not they included some of
`the same clinical tests (alkaline phosphatase
`cholinesterase) employed by Kochanov. Hood
`et al. detected no depression in growth rate or
`pathologic change whereas, presumably because of
`the higher CTFE concentration, Kochanov did,
`and cites nonspecific congestive changes in some
`organs, but without a significant decline in body
`weight values.
`A second chronic toxicity study (12) was under-
`taken by Kochanov, using rats and rabbits exposed
`
`262
`
`Page 8 of 13
`
`to 250 ppm CTFE, 6 hr/day over a period of 70 to
`110 days. Only rabbits showed a decline in growth,
`as was true of the first series Kochanov conducted.
`
`Rat growth lagged only slightly behind that of con-
`trols. Rabbits displayed an increase in heart rate
`when held in an upright position and a slowed heart
`rate recovery period. Hematology of the rabbits
`disclosed a hypochromic anemia. reduction of the
`hemoglobin concentration, and number of erythro-
`cytes; he also saw leucopenia. Hood et al. did not
`report hematologic changes in rabbits, but
`leucopenia was observed by them in dogs.
`Kochanov's rats displayed a considerable reduc-
`tion in their ability to integrate subliminal impulses,
`and oxygen consumption was increased.
`What do these experiments of Hood et al. (10)
`and Kochanov (12) mean with regard to biologic
`activity and health hazards of the fluoroalkenes?
`Much! CTFE, for example, emerges as a com-
`pound of widespread biologic activity capable of
`provoking changes in the central nervous. respira-
`tory, hematopoietic, and renal systems.
`
`Perfluoroisobutylene (PFIB), Repeated
`Exposures
`
`Clayton (5) has reported the repeated exposure
`toxicity of PFIB. This was a short experiment.
`
`Environmental Health Perspectives
`
`

`
`considering the extreme toxicity of this compound
`and thus the need to evaluate its toxicity. Rats were
`exposed to 0.1 ppm for 4 hr/day for 10 days. None
`of the four rats died. During the exposures the rats
`were occasionally restless and developed
`tachypnea. Two of the four rats showed moist rales
`and all appeared cyanotic occasionally. Some body
`weight losses occurred but not of sufficient mag-
`nitude to depress the growth curve. At the end of
`the 2-we

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket